SCI Pharmtech offers high-quality, cost-effective APIs, advanced intermediates, & custom products with global expertise and precision.
KEY PRODUCTS
Reset all filters
01 1SCI Pharmtech
Reset all filters
01 1BRINZOLAMIDE
Reset all filters
01 1Taiwan
Reset all filters
01 1Active
Reset all filters
01 1Complete
SCI Pharmtech offers high-quality, cost-effective APIs, advanced intermediates, & custom products with global expertise and precision.
GDUFA
DMF Review : Complete
Rev. Date : 2016-05-20
Pay. Date : 2015-09-25
DMF Number : 29746
Submission : 2015-09-04
Status : Active
Type : II
20
Sci Pharmtech Inc, based in Taiwan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for SCI Pharmtech offers high-quality, cost-effective APIs, advanced intermediates, & custom products with global expertise and precision.
One of their notable products is BRINZOLAMIDE, with a corresponding US DMF Number 29746.
Remarkably, this DMF maintains an Active status since its submission on September 04, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 20, 2016, and payment made on September 25, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II